<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Briefs</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>BioWorld and Nasdaq stock indices</title>
      <description>
        <![CDATA[These graphs compare the performance of the biotech stocks for all of 2026 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.]]>
      </description>
      <guid>http://www.bioworld.com/articles/731099</guid>
      <pubDate>Fri, 08 May 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731099-bioworld-and-nasdaq-stock-indices</link>
    </item>
    <item>
      <title>Biopharma money raised: Jan. 1-May 7, 2026</title>
      <description>
        <![CDATA[Year-to-date money raised in public, private and other financings of biopharma companies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/731094</guid>
      <pubDate>Fri, 08 May 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731094-biopharma-money-raised-jan-1-may-7-2026</link>
    </item>
    <item>
      <title>Money raised by biopharma</title>
      <description>
        <![CDATA[Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/731093</guid>
      <pubDate>Fri, 08 May 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731093-money-raised-by-biopharma</link>
    </item>
    <item>
      <title>Biopharma money raised by month in 2026 (US$M)</title>
      <description>
        <![CDATA[Biopharma money raised to-date and by month in 2026, including public, private and other financings.]]>
      </description>
      <guid>http://www.bioworld.com/articles/731098</guid>
      <pubDate>Fri, 08 May 2026 12:25:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731098-biopharma-money-raised-by-month-in-2026-usm</link>
    </item>
    <item>
      <title>Regulatory actions for May 8, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730991</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730991-regulatory-actions-for-may-8-2026</link>
    </item>
    <item>
      <title>Other news to note for May 8, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bioora, GSK, Halozyme, Novartis, Novo Nordisk, Oragenics, Signy, Wellington Zhaotai.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730990</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730990-other-news-to-note-for-may-8-2026</link>
    </item>
    <item>
      <title>In the clinic for May 8, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Aim, ALX, Bayer, Cardiol, Delphi, Engene, Entrada, Incyte, Rapid Medical, Totus.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730989</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730989-in-the-clinic-for-may-8-2026</link>
    </item>
    <item>
      <title>Financings for May 8, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Anagram, Cartography, Cytokinetics, Parcelbio, Scienture, Travere, Viridian.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730988</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730988-financings-for-may-8-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for May 8, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Argenx, Becton Dickinson, Bionano Genomics, Eko Health, Endologix, Kuros, Leonabio, Lifescan, Lift, Marius, MBX, Microsure, Parabilis, Torl.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730987</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730987-appointments-and-advancements-for-may-8-2026</link>
    </item>
    <item>
      <title>Today's news in brief</title>
      <description>
        <![CDATA[BioWorld briefs for May 8, 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/432891</guid>
      <pubDate>Fri, 08 May 2026 10:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/432891-todays-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for May 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artera, Bridgebio, Diakonos, Norgine, Nuvation.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730977</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730977-regulatory-actions-for-may-7-2026</link>
    </item>
    <item>
      <title>Other news to note for May 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Acea, Biontech, Boehringer Ingelheim, Deuteroncology, Eli Lilly, Epik, Halozyme, Lucent Diagnostics, Lunai Bioworks, Mannkind, Oncotelic, Oruka, Pathos AI, Phoenix Asia, Ribocure, Scilex Holding, Suzhou Ribo Life, Tempus AI, United Therapeutics.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730976</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730976-other-news-to-note-for-may-7-2026</link>
    </item>
    <item>
      <title>In the clinic for May 7, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Aptevo, Atossa, Avalo, Bioxodes, Braintree, Cairn Surgical, Eupraxia, Helio Genomics, Hoth, Lytix, Medicus, Mingmed, Spago, Verrica.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730975</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730975-in-the-clinic-for-may-7-2026</link>
    </item>
    <item>
      <title>Financings for May 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Aura, Avalo, Cellcentric, Citius Oncology, Inflarx, Kanvas, LTZ, Neurospectrum Insights, Signadori.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730974</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730974-financings-for-may-7-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for May 7, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Abli, Actuate, Anavex, Cellprothera, Cristcot, Cytora, Immutrin, Turbett Surgical.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730973</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730973-appointments-and-advancements-for-may-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 6, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Clear Scientific, Fate, Multi4, Neurocare, Opus Genetics, Ultragreen.ai.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730873</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730873-regulatory-actions-for-may-6-2026</link>
    </item>
    <item>
      <title>Other news to note for May 6, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Assertio, Elaris, Garda, Matrivax, Profusa.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730872</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730872-other-news-to-note-for-may-6-2026</link>
    </item>
    <item>
      <title>In the clinic for May 6, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Cellectar, Cytokinetics, Earlydiagnostics, Eli Lilly, Eupraxia, J&J, Ocugen, Palisade, Regeneron, Sanofi, Telix, Viridian.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730871</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730871-in-the-clinic-for-may-6-2026</link>
    </item>
    <item>
      <title>Financings for May 6, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: 4D Path, Abivax, Cellectar, Clene, Hemab, Ocugen, Picard Medical, Senseonics.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730870</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730870-financings-for-may-6-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for May 6, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: 4D Path, Basking, Brainscope, Coopercompanies, Diagonal, Discure, GC, Integra, Mana.bio, Pilatus, Sail, Tris, Valion, Viatris.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730869</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730869-appointments-and-advancements-for-may-6-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 5, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied Biocode, Arvinas, Atossa, Clene, E-scopics, Incyte, Lanexa, Pfizer, Satellite, Specialised, Sunshine, Zeta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730859</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730859-regulatory-actions-for-may-5-2026</link>
    </item>
    <item>
      <title>Other news to note for May 5, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Amgen, Biocryst, Cullgen, Endorobotics, Gyre, Macrogenics, Neopharmed, Olympus.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730858</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730858-other-news-to-note-for-may-5-2026</link>
    </item>
    <item>
      <title>In the clinic for May 5, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Alto, Cairn, Celcuity, Dr. Falk, Edwards, J&J, Mirum, Neurocrine, Renexxion, Rezolute, Rhythm, Takeda.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730857</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730857-in-the-clinic-for-may-5-2026</link>
    </item>
    <item>
      <title>Financings for May 5, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Aura, Avalyn, Cabaletta, CNS, Latus, Mobia Medical, Odyssey, Windward.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730856</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730856-financings-for-may-5-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for May 5, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Aura, Confluent, Eupraxia, Kyverna, Legend, Medcura, Pasithea, Spruce, Tenax.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730855</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730855-appointments-and-advancements-for-may-5-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 5, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Claruvis, Curocell, Dr. Reddy’s, Emergent, Henlius, Hutchmed, Kyowa Kirin, Orchard, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730901</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730901-regulatory-actions-for-may-5-2026</link>
    </item>
    <item>
      <title>Other news to note for May 5, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: AC Immune, Aptose, Cipla, Dexcel, Hanmi Hikma, Noxopharm, Pfizer, Takeda.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730900</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730900-other-news-to-note-for-may-5-2026</link>
    </item>
    <item>
      <title>In the clinic for May 5, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Brii, Restore Vision, Telix, TLC.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730899</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730899-in-the-clinic-for-may-5-2026</link>
    </item>
    <item>
      <title>Financings for May 5, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Vivacta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730898</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730898-financings-for-may-5-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for May 5, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Nuevocor, Paratus Sciences.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730897</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730897-appointments-and-advancements-for-may-5-2026</link>
    </item>
  </channel>
</rss>
